BlackBarn Capital Partners LP lifted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 65.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 663,397 shares of the company's stock after purchasing an additional 263,397 shares during the period. Privia Health Group accounts for approximately 0.7% of BlackBarn Capital Partners LP's portfolio, making the stock its 10th biggest holding. BlackBarn Capital Partners LP owned 0.55% of Privia Health Group worth $12,969,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in PRVA. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after buying an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group in the 4th quarter valued at approximately $51,000. Quadrant Capital Group LLC lifted its position in shares of Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after acquiring an additional 511 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in shares of Privia Health Group by 185.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after purchasing an additional 3,249 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.
Privia Health Group Stock Performance
NASDAQ PRVA traded down $0.29 during trading hours on Friday, reaching $23.17. 383,161 shares of the company's stock were exchanged, compared to its average volume of 775,054. The company has a market capitalization of $2.81 billion, a price-to-earnings ratio of 231.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. The company's 50-day moving average is $23.64 and its two-hundred day moving average is $21.87. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04.
Insider Transactions at Privia Health Group
In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares of the company's stock, valued at $4,021,148.88. This represents a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 10.70% of the stock is owned by insiders.
Analyst Ratings Changes
PRVA has been the subject of several research reports. Robert W. Baird raised their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Truist Financial lifted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. Barclays lifted their price objective on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Finally, Canaccord Genuity Group boosted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $27.14.
Read Our Latest Analysis on Privia Health Group
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
